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ABSTRACT 
Cisplatin is an effective chemotherapeutic agent for solid tumors; however its use is limited by nephrotoxicity. The current study investigated the 
effect of Butea monosperma in cisplatin-induced nephrotoxicity and oxidative stress in rats. Kidneys have a vital role in the normal physiology of 
humans. Worldwide chronic kidney disease has become a major cause for disability and in worst circumstances leads to death. Major renal 
disorders occur due to diabetes and its complications termed as diabetic nephropathy (DN). The animals were divided into four groups of six 
rats each (n=6). The control group (Group 1) received 1%CMC, Group 2 received only cisplatin, a 7 days of extract of Butea monosperma (200 
mg/kg bwt) pre-treatment was applied to the animals in Group 3 before administration of cisplatin; a 7 days of extract of Butea monosperma was 
performed following administration of cisplatin for the animals in Group 4. Cisplatin (6 mg/kg) was intraperitoneally injected as a single dose 
and extract of Butea monosperma (200 and 400 mg/kg bwt) was administered by gavage in 1%CMC. Biochemical and histopathological methods 
were utilized for evaluation of the nephrotoxicity. The concentrations of creatinine, uric acid and blood urine nitrogen, in plasma and levels of 
malondialdehyde and reduced glutathione as well as glutathione peroxidase and catalase activities were determined in kidney tissue. 
Administration of cisplatin to rats induced a marked renal failure, characterized with a significant increase in plasma creatinine and uric acid and 
Blood urea nitrogen. levels of rats received cisplatin alone were significantly different compared to control group but they had higher kidney 
malondialdehyde, and lower reduce glutathione concentrations, superoxide dismutase and catalase activities. Extract of Butea monosperma 
administration produced amelioration in biochemical indices of nephrotoxicity in both serum and kidney tissues when compared to toxic 
inducer group; pre-treatment with extract of Butea monosperma being more effective. Results from this study indicated that the novel natural 
antioxidant extract of Butea monosperma might have protective effect against cisplatin-induced nephrotoxicity and oxidative stress in rat. 
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INTRODUCTION 
The important role of kidneys in normal physiology 
comprises plasma filtration of metabolic waste products, 
regulation of plasma volume, hormone secretion and acid-
base balance. Any changes in the above indicators lead to a 
large number of diverse, life threatening renal diseases. 
Globally, the 12th cause of death in humans is due to chronic 
kidney disease (CKD) and leads to 17th cause of disability. 
People with CKD are more prone to cardiovascular disorders 
(CVD) rather than to reach end-stage renal disease (ESRD) 1. 
Around 30% of diabetes mellitus patients (DM) fall ill with 
diabetic nephropathy (DN) and CKD incidence. According to 
the Diabetes Atlas 2006 (India), patient’s population with 
DM is presumed to rise to 69.9 million by 2025 in the 
absence of preventive measures2. From the classical times 
the nature stands a golden mark and provided the armory of 
remedies to cure all ailments of mankind. Herbs have always 
been the predominant form of medicine in India and 
currently they are becoming popular globally. India has an 
age old system of medicine known as Ayurveda system along 
with some other traditional system such as Siddha and 
Unani. There is rampant change in the international interest 
of herbal medicines3. Medicinal plants play a major role in 
research and new drug development in the field of 
pharmaceutical science. Cisplatin is a standout amongst the 
most broadly utilized anticancer medications for the 
treatment of different tumors4. However, in spite of its wide 
therapeutic benefits as an anticancer drug, its clinical use is 
limited due to its dose dependent hepatonephrotoxicity5. 
Although intensive prophylactic measures, irremediable 
renal and hepatic damage occurs within days in nearly one-
third of cisplatin-treated patients6,7. There are many 
evidences that cisplatin induces oxidative stress which plays 
a critical role in liver and kidney diseases8,9. Oxidative stress 
was attributed to the combination of multi-ways, such as the 
generation of reactive oxygen species (ROS), which could 
interact with the antioxidant defense system and cause 
oxidative damage in different tissues and reaction with 
glutathione and thiols in protein, which could lead to cell 
dysfunction in liver and kidney10. Reactive oxygen species 
(ROS) directly act on cellular units such as, proteins, lipids 
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and DNA to devastate their structure11. The free radicals 
devastate the lipid units of the cell membrane by denaturing 
proteins and peroxidation, causing enzymatic deactivation 
and lead to mitochondrial dysfunction12. Previous literature 
revealed that kidney toxicity and oxidative stress caused by 
cisplatin was decreased by the various methods. The method 
includes antioxidant including sodium selenite13, 14, Vitamin 
C15, 16, curcumin17 and the carotenoid bixin18, 19. Butea 
monosperma, is a moderate sized deciduous tree, belonging 
to fabaceae family. It is known as The Flame of forest or 
Bastard teak in English and Palash or dhak in Hindi They 
consists one of the largest families of flowering plants with 
630 genera and 18000 species. The genus Butea includes 
Butea monosperma parviflora, Butea minor and Butea 
superba widely distributed throughout India. It is elucidated 
in Upanishads, Vedas, Susrirta Samhita, Charaka Samhita, 
Astanga Sangraha, Ashtanga Hrdaya20. This is a moderate 
sized deciduous tree which is widely distributed throughout 
India, Burma and Ceylon extending in the North West 
Himalayas as far as Jhelum except in very acrid parts21. It is 
considered as a sacred tree. It grows well in the alkaline, 
marshy condition in sunny location. The number of different 
chemical constituents obtained from various parts of the 
plant are used as anti-inflammatory,anti-diabetic,anti-
fungal,anti-asthamatic,astringent, aphrodisiac22.The gum 
which is obtained from the slit made on the bark of the tree 
is known as ‘kamarkas’ or Bengal Kino which is rich source 
of tannins. The dyeing agent present in the flowers that 
imparts its color is used as insecticide and coloring agent. 
The flavonoids Butin, Butein, Butrin, Isobutrin, Palasitrin, 
Coreopsin, Isocoreopsin, Sulphuresin, Monospermoside, 
Isomonospermoside and 7,3,4- trihydroxyflavone have been 
isolated from the flower of this plant. From the stem and the 
pods of this plant species Euphane triterpenoid 3a-
hydroxyeuph-25-ene and the alcohol 2, 14-dihydroxy-11, 12-
dimethyl-8-oxo-octadec-11- enylcyclohexane and Imide 
palasimide has been isolated respectively. It acts as the host 
for lac insect and plays a role in the production of lac23. Bark 
fibers are utilized for making cordage. Wood pulp is useful 
for newsprint manufacturing24. The aim of the current study 
is to investigate the effect of Butea monosperma in cisplatin-
induced nephrotoxicity in rats. 
MATERIAL AND METHODS 
Collection and authentication of plant material 
Leaves of Butea monosperma were collected in August-
October locally from Bhopal (M.P.). Special precautions were 
taken to collect healthy plants avoiding foreign materials. 
Herbarium of plant were prepared and submitted for 
authentication to Safia College of Science (Department of 
Botany), Bhopal, India. Authentication was done by Dr. Zia-
Ul-Hasan, botanist (Head, Department of Botany). 
Authentication voucher number was 448/Bot/Saifia/13.  
Chemicals 
Cisplatin (Himedia) was purchased from Himedia, India, 
GSH, glutathione reductase, thiobarbituric acid, hydrogen 
peroxide, NADPH, ethanol, NBT, PMS and other reagents 
were supplied from Sigma (Mumbai, India). 
Extraction 
In the present study, extraction was performed using 
continuous hot Soxhalation25. Pulverised and weighed 
quantity of dried leaves of B. monosperma was placed in 
thimble of Soxhlet apparatus. Extraction was performed 
using petroleum ether, followed by methanol. For each 
solvent, soxhalation was continued till no colour was 
observed in siphon tube and completion of extraction was 
confirmed till solvent in the siphon tube does not left any 
residue after evaporation. Obtained extracts were 
concentrated under vacuum at 40°C-45°C. The extracts were 
further dried in shade. Dried extracts were weighed and 
percentage yield for extract was determined and packed in 
air tight container and labelled for further use. 
Acute oral toxicity 
The acute toxicity study was performed for Butea 
monosperma extract according to OECD (423) guidelines. 
Wistar rats were selected randomly. The test groups include 
four treatment groups with dosages at 5 mg/kg, 50 mg/kg, 
300 mg/kg and 2000 mg/kg body weight. Individual doses 
were calculated on the basis of body weight of the animal on 
the day of treatment. The animals were observed almost 
constantly for behavioral changes, mortality and appearance 
during firstly for first 4 hours, periodically during the 24 
hours and then every day for a period of two weeks. 
Animals 
In this investigation, 24 healthy adult Albino wistar rats 
either sex (8 weeks old weighing 150–200 g) were used. The 
animals were obtained from the Pinnacle Biomedical 
Research Institute, Bhopal (M.P.), India. The animals were 
kept under standard laboratory conditions (12-h light: 12-h 
dark and 24 ± 3 ◦C). Animals were provided with food and 
water ad libitum. Experiments were strictly conducted and 
approved by Animal ethics Committee, Pinnacle Biomedical 
Research Institute, Bhopal, M.P., INDIA (Reg: 
1824/PO/c/09/CPCSEA and protocol reference no. 
PBRI/IAEC/PN-17069). 
Experimental design 
The rats were divided into four groups; each group 
containing six rats. Cisplatin was injected to animals’ intra-
peritoneally at the dose of 6 mg/kg, which is well 
documented to induce nephrotoxicity in rats25, 27. Methanolic 
leaf extract of Butea monosperma was administered to 
animals by gavage orally at the doses of 200 mg/kg and 400 
mg/kg body weight once daily for 7 days. The dose Butea 
monosperma extract used in this study was selected on the 
basis of the acute oral toxicity28.  Group 1 (control) received 
0.1% CMC daily for 7 days, Group 2 received 0.1% CMC drug 
orally for 7 days and a single dose cisplatin on 7th day intra-
peritoneally post dosing of CMC. Group 3 and Group 4 
received extract of Butea monosperma at a dose of 200 and 
400mg/kg bw orally once daily respectively and a single 
dose of Cisplatin (6 mg/kg bwt) in both group post dosing of 
extract. 
Sample collection 
At termination of experiments, animals of each group were 
sacrificed at the 8th day. Blood samples were collected and 
samples were centrifuged at 200 × g for 5 min at +4 ◦C to 
separate their plasma and one of the kidney tissue samples 
was kept it in 0.2M Phosphate buffer for further analysis.  
In-vivo antioxidant assay 
Kidney tissue were dissected out and homogenized. Briefly, 
tissues were weighed and homogenized with buffers 
(provided by the kits). The homogenates were then 
determined following the procedures to study the enzyme 
activity via catalase (CAT), glutathione peroxidase (GPx), 
superoxide dismutase (SOD) and LPO spectrophoto 
metrically (UV spectrophotometer – Model Systronic 2202). 
Superoxide dismutase 
The Superoxide Dismutase Assay Kit utilizes a tetrazolium 
salt for detection of superoxide radicals generated by red 
formazan dye reduction produced. One unit (U) of SOD 
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activity is defined as the amount of enzyme needed to exhibit 
50% dismutation of the superoxide radical. Briefly, 0.1 ml 
sample was added with 1.2 ml of 0.052M sodium 
pyrophosphate buffer 0.1 ml of 186 µM phenazine 
methosulphate  + 0.3 ml of 300  µM Nitroblutetrazolium + 
0.2 ml of 750 µM NADH. Incubate at 30°C for 90 seconds Add 
0.1 ml glacial acetic acid Stir with 4.0 ml n-butanol Allow to 
stand for 10 min Centrifuge and butanol layer were separate.  
The reduction was measured at 560 nm in UV 
spectrophotometer – Model Systronic 2202 and percentage 
of SOD inhibition as compared to the blank was determined. 
One unit of SOD was calculated by the amount of protein 
needed to achieve the 50% inhibition and hence expressed 
as unit SOD/mg protein29. 
Malondialdehyde (MDA)  
Tissue peroxidation value was detected by measuring 
thiobarbituric acidreactive substance (TBARS). In brief, 0.2 
ml of aliquot was added with 0.2 ml 8.1 % SDS, 1.5 ml 20 % 
acetic acid, 1.5 ml 8 % TBA (make up volume up to 4 ml with 
distilled water). Heat on water bath (95°C) for 60 min using 
glass ball as condenser, cool and make up volume up to 5 ml 
Add 5 ml of butanol : pyridine (15:1). The mixture was 
vortex for 2 minutes then centrifuge at 3000 rpm for 10 min. 
take out the upeer layer form the mixture and then 
absorbance of pink-colored product was taken at 532 and 
600 nm wavelength using UV-Vis Spectrophotometer 
(Systronic-2202). The difference between absorbance was 
measured and compared to that of the standard 
malonaldehyde tetramethyl acetal solutions of different 
concentrations. MDA activity was expressed as nmol MDA/g 
protein30. 
Glutathione peroxidase  
The Glutathione Peroxidase Assay Kit measures GPx activity 
indirectly by a coupled reaction With GR. Oxidized 
glutathione, produced upon reduction of hydroperoxide by 
GPx, is recycled to its reduced state by GR and NADPH. The 
oxidation of NADPH to NADP+ is accompanied by adecrease 
in absorbance at 340 nm. Under conditions in which the GPx 
activity is rate limiting, the rate of decrease in the A340 is 
directly proportional to the GPx activity. One unit (U) of GPx 
activity is defined as the amount of enzyme that will cause 
the oxidation of 1.0 nmol of NADPH to NADP+ per minute at 
25oC 31. 
Catalase  
CAT activity was determined by measuring the 
decomposition of hydrogen peroxide at 240 nm and was 
expressed as k/g protein, where k is the first-order rate 
constant. Protein concentrations were measured32. 
Biochemical assays  
Plasma creatinine, Blood urea nitrogen, uric acid were 
measured by using test kit (Span Diagnostics Ltd.) in 
biochemical auto analyzer (Star 21 plus-E119147).   
Histopathological examinations 
The other kidney was excised after sacrifice. The tissues 
were fixed in 10% formalin, embedded in paraffin, sectioned 
at 5 mm and were stained with hematoxylin–eosin.  
Statistical analysis 
All data were calculated as Mean ± SD. Results were analyzed 
using One Way ANOVA followed by Bonferroni’s test. P<0.05 
was considered as level of significance. 
RESULTS  
In acute oral toxicity study, the methanolic extract of Butea 
monosperma were employed as per OECD guideline in wistar 
rats. Extract did not show any mortality and toxicity at any 
concentration not even at highest does of 2000 mg. kg-1. 
Therefore, in present study 200mg (low) and 400mg (high) 
doses of methanolic drug extract were selected for 
determination of nephrotoxicity activity. In invivo oxidative 
stress study parameters, the production of MDA level in the 
renal tissue were assessed as a measure of LPO. A single dose 
of cisplatin increased the formation of lipid peroxides 24 h 
after i.p. cisplatin, compared to control groups (P < 0.05). 
This increase was inhibited by administration of methanolic 
extract of Butea monosperma in rats sacrificed on 8th day 
after cisplatin administration (P > 0.05). Kidney tissues in 
cisplatin-treated group showed a statistically significant 
reduction in the MDA production in animals as compared to 
pretreated with methanolic extract of Butea monosperma (P 
< 0.05). The SOD level were decrease in Cisplatin injected 
group whereas pretreated with extract group shows 
significant increment in the SOD level but did not reach the 
level of control group. In the cisplatin treated group, the 
cisplatin dose resulted in decrease in renal glutathione, after 
treatment as compared to the control group (P < 0.05). The 
levels of renal glutathione were restored to normal level in 
group 4 as compared to the control group (P < 0.05). 
Likewise in catalase assay decomposition of hydrogen 
peroxide is decreased in ciplatin induced group whereas 
extract pretreated group shows increment in the catalase 
level Table 1. In the cisplatin induced nephrotoxicity study 
using cisplatin as inducer, the protective effects of 
methanolic extract of Butea monosperma reach those of the 
control group. Table 2 showed the effects of oral extract of 
Butea monosperma on cisplatin mediated increases in serum 
creatinine and decreases in creatinine clearance 24h after 
the i.p. treatment. The cisplatin alone led to augment the 
value of serum creatinine compared to the control group (P < 
0.05). A significant decline in the level of creatinine (P < 
0.05) was observed in rats treated with cisplatin and Butea 
monosperma extract when compared to the control group. 
Blood urea nitrogen also increased in cisplatin induced 
group but pre treated with methanolic extract of Butea 
monosperma decreases the level of BUN similarly the Uric 
acid level also increased in cisplatin induced group whereas 
pretreated with extract significantly decreased the level. 
 
Table 1: Chemoprotective activity against cisplatin induced nephrotoxicity 
Group 
No. 
Treatment Group 
Enzymes involved in oxidative stress in Kidney (Mean ± SD) 
LPO  
(nM MDA/gm 
wet tissue) 
SOD  
(U/gm wet 
tissue) 
GSH  
(nmol/gm wet 
tissue) 
Catalase  
(U/gm wet 
tissue) 
1 Control 8.17±0.753 14.50±1.871 65.50±7.036 21.17±2.229 
2 Control + Cisplatin 75.17±5.037* 2.07±0.574* 19.33±4.502* 4.89±1.812* 
3 Extract (200mg/kg bwt) + Cisplatin 54.33±4.761# 3.41±0.369# 23.83±2.483# 6.50±1.265# 
4 Extract (400mg/kg bwt) + Cisplatin 45.50±3.728# 4.89±0.630# 29.50±2.258# 7.35±0.477# 
 (* – p<0.05 compared to Group I (vehicle treated group); #- p<0.05 as compared to group II [Cisplatin (6mg/kg, i.p)], n=3) 
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Table 2: Effect of methanolic extract of Butea monosperma on kidney function test in rats treated with cisplatin 
Group No. Group No. 
Kidney function test (Mean ± SD) 
Creatinine BUN Uric Acid 
1 Control 0.08±0.009 10.17±2.317 1.16±0.169 
2 Control + Cisplatin 3.87±0.389* 57.31±5.981* 61.78±5.212* 
3 Extract (200mg/kg bwt) + Cisplatin 2.77±0.328# 48.79±2.728# 43.28±4.618# 
4 Extract (400mg/kg bwt) + Cisplatin 2.17±0.228# 42.99±3.136# 34.37±3.701# 
(* – p<0.05 compared to Group I (vehicle treated group); #- p<0.05 as compared to group II [Cisplatin (6mg/kg, i.p)], n=3) 
Histopathological Studies 
Histopathological study was performed using light microscopy. In control group, kidney showing tubular brush borders and 
intact glomeruli without any structural alterations in renal tissues. In cisplatin treated group showed swelling and massive and 
diffuse cell necrosis in proximal tubules of kidneys indicating injury. Pretreatment with Methanolic extract of Butea monosperma 
was significantly prevented histopathological changes. This inhibitory action Methanolic extract of Butea monosperma against 
cisplatin was confirmed through histopathological studies Figure 1. 
 
Group 1: Control    Group 2: Inducer (Csiplatin) 
 
Group 3: Extract treated (200mg/kg bwt) Group 4: Extract treated (400mg/kg bwt) 
Figure 1: Photomicrograph of renal sections showing a protective effect of methanolic extract of Butea monosperma cisplatin-
induced tubular damage. Group 1: control group, Group 2: Toxic control group, Group 3 Treatment group with 200 mg/kg, orally 
of methanolic extract of Butea monosperma, Group 4: Treatment group with 400 mg/kg, orally of methanolic extract of Butea 
monosperma. The details of histology pictures were as A: PCT- proximal convoluted tubule, B: Normal Glomerulli, C: DCT- distal 
convoluted tubule, D: Vacuolated cytoplasm, peritubular capillary dilation and congestion E: pyknosis, F: Dehydrated Bowman’s 
Capsule, G: Bowman’s space reached to its normal position 
DISCUSSION  
The exact mechanism of cisplatin-induced nephrotoxicity is 
unknown while studies supporting the involvement of lipid 
peroxidation and free radicals. Cisplatin generates ROS such 
as superoxide anion and hydroxyl radicals, and stimulates 
renal lipid peroxidation33, 34. The study regarding the role of 
lipid peroxidation and its position in the chain of events that 
leads to nephrotoxicity still controversial. The study in which 
free radical generation is not the direct cause of cisplatin-
induced renal injury was supported by Kruidering 35. In 
present study, the administration of cisplatin resulted in 
damage, evaluated by the increase in the MDA content when 
compared to control group. These data are supported by 
previous investigations where this antitumoral induced lipid 
peroxidation and damage in the renal tissues of rats. The 
increase in renal MDA content 24h after cisplatin injection 
was significantly prevented by pretreatment with extract, 
but it was not observed in animals sacrificed at 24 h. It was 
evidenced that cisplatin nephrotoxicity occurs as a result of 
oxidative stress and increased generation of superoxide 
anion, hydrogen peroxide, and hydroxyl radicals due to the 
increased activity of NADPH oxidase and adenosine 
deaminase 36.  These ROS damage the lipid gears of the cell 
membrane via proteins denaturation, which subsequently 
lead to enzymatic inactivation 37. Moreover, cisplatin induced 
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kidney damage could be explained by the fact that, as fast as 
cisplatin is in the interior of the cells, the hydrolysis product 
reacts with GSH in the cytoplasm and DNA in the nucleus 38. 
The produced cisplatin-DNA intrastrand cross-links result in 
cytotoxicity (apoptosis/ necrosis) 39. 
CONCLUSION 
Finally, on the basis of these investigations, we may partially 
conclude that the methanol extract of Butea monosperma 
with antioxidant properties could be a potent 
nephroprotective and curative agent for the next generation. 
The nephroprotective effects of the doses of Butea 
monosperma were accompanied with attenuation of 
cisplatin-induced alteration in oxidative stress. 
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